Literature DB >> 11042559

Expression of ets-1 transcription factor is correlated with penetrating tumor progression in patients with squamous cell carcinoma of the esophagus.

H Saeki1, H Kuwano, H Kawaguchi, S Ohno, K Sugimachi.   

Abstract

BACKGROUND: The Ets-1 transcription factor is proposed to play a role in tumor invasion. To evaluate the biologic significance of Ets-1 in the progression of squamous cell carcinoma of the esophagus, the authors investigated Ets-1 expression in tumors from 90 patients using immunohistochemical procedures.
METHODS: The Ets-1 positive ratio (Ets-1 ratio) was determined in the center and deep margin areas of invasive sites and in the center and outer edge areas of intraepithelial spread contiguous with invasive disease.
RESULTS: Ets-1 expression was heterogeneous within tumor tissue. The Ets-1 ratio was significantly higher at invasive sites compared with intraepithelial spread sites, and at deep margin areas compared with center areas (P < 0.0001 and P < 0.05, respectively, by two-way analysis of variance). No differences were noted in the Ets-1 ratio at the deep margin areas at each depth of invasion. Investigating the Ets-1 ratio at deep margin areas in each pathologic phenotype, the ratio of the small nest type was found to be higher than that of the large nest type (P < 0.0001).
CONCLUSIONS: The authors propose that Ets-1 plays an important role in penetrating tumor progression, even very early in the invasive process (especially in the case of infiltrative invasive type tumors) at the deep margin areas of invasive sites in patients with squamous cell carcinoma of the esophagus. Copyright 2000 American Cancer Society.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11042559     DOI: 10.1002/1097-0142(20001015)89:8<1670::aid-cncr4>3.0.co;2-j

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  14 in total

1.  Ets1 blocks terminal differentiation of keratinocytes and induces expression of matrix metalloproteases and innate immune mediators.

Authors:  Priyadharsini Nagarajan; Shu Shien Chin; Dan Wang; Song Liu; Satrajit Sinha; Lee Ann Garrett-Sinha
Journal:  J Cell Sci       Date:  2010-10-15       Impact factor: 5.285

2.  Ets-1 and VEGF expression correlates with tumor angiogenesis, lymph node metastasis, and patient survival in esophageal squamous cell carcinoma.

Authors:  Tina Mukherjee; Anupam Kumar; Meera Mathur; Tushar Kant Chattopadhyay; Ranju Ralhan
Journal:  J Cancer Res Clin Oncol       Date:  2003-07-08       Impact factor: 4.553

3.  Ets-1 is required for the activation of VEGFR3 during latent Kaposi's sarcoma-associated herpesvirus infection of endothelial cells.

Authors:  Kimberley D Gutierrez; Valerie A Morris; David Wu; Serge Barcy; Michael Lagunoff
Journal:  J Virol       Date:  2013-04-03       Impact factor: 5.103

4.  Ets-1 gene expression in patients with thymoma.

Authors:  Hidefumi Sasaki; Yoshihiro Kobayashi; Masayuki Tanahashi; Haruhiro Yukiue; Motoki Yano; Masahiro Kaji; Masanobu Kiriyama; Ichiro Fukai; Yosuke Yamakawa; Yoshitaka Fujii
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2002-12

5.  The ERK MAP kinase-PEA3/ETV4-MMP-1 axis is operative in oesophageal adenocarcinoma.

Authors:  Richard Keld; Baoqiang Guo; Paul Downey; Christian Gulmann; Yeng S Ang; Andrew D Sharrocks
Journal:  Mol Cancer       Date:  2010-12-09       Impact factor: 27.401

Review 6.  The biology of the Ets1 proto-oncogene.

Authors:  Jürgen Dittmer
Journal:  Mol Cancer       Date:  2003-08-20       Impact factor: 27.401

7.  Aberrant epidermal differentiation and disrupted ΔNp63/Notch regulatory axis in Ets1 transgenic mice.

Authors:  Shu Shien Chin; Rose-Anne Romano; Priyadharsini Nagarajan; Satrajit Sinha; Lee Ann Garrett-Sinha
Journal:  Biol Open       Date:  2013-12-15       Impact factor: 2.422

8.  Differential expression of miR-1, a putative tumor suppressing microRNA, in cancer resistant and cancer susceptible mice.

Authors:  Jessica L Fleming; Dustin L Gable; Somayeh Samadzadeh-Tarighat; Luke Cheng; Lianbo Yu; Jessica L Gillespie; Amanda Ewart Toland
Journal:  PeerJ       Date:  2013-04-16       Impact factor: 2.984

9.  Ets1 induces dysplastic changes when expressed in terminally-differentiating squamous epidermal cells.

Authors:  Priyadharsini Nagarajan; Neha Parikh; Lee Ann Garrett-Sinha; Satrajit Sinha
Journal:  PLoS One       Date:  2009-01-14       Impact factor: 3.240

10.  PAX3 and ETS1 synergistically activate MET expression in melanoma cells.

Authors:  J D Kubic; E C Little; J W Lui; T Iizuka; D Lang
Journal:  Oncogene       Date:  2014-12-22       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.